1000 related articles for article (PubMed ID: 11953071)
1. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of polycystic ovary syndrome and related infertility with clomiphene resistance by compound cyproterone acetate].
Tao Y; Dai Q; Zhang D
Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):528-32. PubMed ID: 11360636
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.
Sönmez AS; Yasar L; Savan K; Koç S; Ozcan J; Toklar A; Yazicioğu F; Akgün A; Sut N
Hum Reprod; 2005 Jan; 20(1):175-9. PubMed ID: 15513975
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
Liu ZA; Xue YM; Chen LX; Cai Q; Chen H; Zhang J; Cui QH; Ge J; Yuan T
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
6. Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).
Horng SG; Wang TH; Wang HS
Chang Gung Med J; 2008; 31(5):477-83. PubMed ID: 19097595
[TBL] [Abstract][Full Text] [Related]
7. [Effects of metformin on gonadotropin-induced ovulation in patients with polycystic ovary syndrome].
Zhao JZ; Ye BL; Lin JJ; Lin WQ; Chi HH
Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):545-8. PubMed ID: 14680609
[TBL] [Abstract][Full Text] [Related]
8. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
10. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
12. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome.
Palomba S; Falbo A; Orio F; Tolino A; Zullo F
Fertil Steril; 2009 Jun; 91(6):2557-67. PubMed ID: 18440534
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
14. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M
Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
Kriplani A; Agarwal N
J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
[TBL] [Abstract][Full Text] [Related]
16. Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome.
Palomba S; Orio F; Falbo A; Russo T; Caterina G; Manguso F; Tolino A; Colao A; Zullo F
Clin Endocrinol (Oxf); 2005 Dec; 63(6):631-5. PubMed ID: 16343096
[TBL] [Abstract][Full Text] [Related]
17. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
Rouzi AA; Ardawi MS
Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
[TBL] [Abstract][Full Text] [Related]
19. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
[TBL] [Abstract][Full Text] [Related]
20. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L
Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]